Fees
IRB Fees
As of July 1, 2023, the University of Virginia implemented a new fee structure for industry-sponsored clinical trials requiring full board IRB review. This new fee structure applies to all studies for which the Clinical Trial Agreement (CTA) is executed on or after July 1, 2023.
The fee will be charged for studies for which the UVA IRB HSR is the IRB of record as well as those studies that are being conducted under a non-UVA IRB.
The revised fee structure is as follows:
| Service | Charge |
| UVA-HSR as IRB of record: initial review | $3,500 |
| Reliance on an outside IRB: initial review | $3,500 |
| UVA-HSR as IRB of record: yearly fee (billed at annual continuation) | $2,000 |
| Reliance on an outside IRB: yearly fee (billed at annual
continuation) |
$1,000 |
| UVA-HSR serving as sIRB of record for non-UVA sites:
initial review |
$1,000 per site |
| UVA-HSR serving as sIRB of record for non-UVA sites:
yearly fee (billed at annual continuation) |
$500 per site |
| Study close-out | $2,500 |
Note: The fee is considered a direct cost and is subject to F&A. Information regarding F&A may be found on the Office of Sponsored Programs.
Questions regarding this fee may be referred to the School of Medicine Clinical Trials office at 434-924-8570.
Study Management Fee
As of July 1, 2024, the University of Virginia will implement a new clinical trial management fee for industry-sponsored clinical trials requiring full board IRB review. The clinical trial management fee reflects costs associated with supporting operations related to the conduct of clinical trials. It is a one-time fee and applies to all studies for which the Clinical Trial Agreement (CTA) is executed on or after July 1, 2024.
| Service | Charge |
| Study Management Fee | $5,000 |
Note: The fee is considered a direct cost and is subject to F&A.
Linda R. Duska, MD, MPH
Lawrence W. Penniston MD Family Endowed Professor of Women’s Oncology Research Associate Dean for Clinical Research, UVA School of Medicine